OCC
ORTHOCELL LIMITED
$0.5700
▲ +1.79%
Market cap
$155M
Turnover
$88,738
Last price
$0.5700
Day change
+1.79%
Announcements
12
Range, past year
Open 1.025 · Low 0.490 · Now 0.570 · High 1.700
Open OCC in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
OCC momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
38/100
Wyckoff phase
Accumulation6d
Trend stage
Neutral
1 Day
+1.8%
1 Week
-3.4%
1 Month
-14.9%
1 Year
-45.5%
RSI
43
Avg daily range
6.0%
ORTHOCELL LIMITED scores 38 out of 100 for momentum quality, a reading rated low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 6 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -36.5%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
OCC announcements
Recent price-sensitive releases.
- 2026-11-03 Marine Biomedical Achieves FDA Clearance Progress Report
- 2026-10-22 Q1 FY27 OCC Investor Presentation Company Presentation
- 2026-10-22 Quarterly Activity Report & Appendix 4C Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
- 2026-10-13 Remplir Shows Excellent Early Prostatectomy Results Progress Report
- 2026-09-21 Orthocell Achieves First Remplir Sales in Thailand Progress Report
- 2026-08-31 Appendix 4E & Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-14 Q4 FY26 ASX Investor Presentation
More Health Care stocks
Most traded in the same sector.